Insider Transactions for Prevail Therapeutics Inc. (PRVL)

Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Tyto Acquisition Corp 10% Owner Jan 22, 2021 Buy $22.50 34,284,789 771,407,753 100 Jan 22, 2021, 04:26 PM
Abeliovich Asa President & CEO Dec 30, 2020 Option Exercise $23.02 89,037 2,049,632 2,385,756 Dec 31, 2020, 04:54 PM
Abeliovich Asa President & CEO Dec 30, 2020 Option Exercise $9.84 125,793 1,237,656 2,474,793 Dec 31, 2020, 04:54 PM
Minkow Emily Chief Business Officer Dec 24, 2019 Option Exercise $0.18 13,000 2,340 13,000 Mar 11, 2020, 04:47 PM
Thompson Peter A. Director Jun 24, 2019 Buy $17.00 882,352 14,999,984 13,822,463 Jun 26, 2019, 04:56 PM
GORDON CARL L Director Jun 24, 2019 Buy $17.00 882,352 14,999,984 13,822,463 Jun 26, 2019, 04:55 PM
ORBIMED ADVISORS LLC Director Jun 24, 2019 Buy $17.00 882,352 14,999,984 13,822,463 Jun 26, 2019, 04:54 PM

Desktop Version

Owner Relationship Date Transaction Value($)
Tyto Acquisition Corp 10% Owner Jan 22, 2021 Buy 771,407,753
Abeliovich Asa President & CEO Dec 30, 2020 Option Exercise 2,049,632
Abeliovich Asa President & CEO Dec 30, 2020 Option Exercise 1,237,656
Minkow Emily Chief Business Officer Dec 24, 2019 Option Exercise 2,340
Thompson Peter A. Director Jun 24, 2019 Buy 14,999,984
GORDON CARL L Director Jun 24, 2019 Buy 14,999,984
ORBIMED ADVISORS LLC Director Jun 24, 2019 Buy 14,999,984